OrthoPediatrics (KIDS) Stock Forecast & Price Target

Compare

113 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

KIDS Analyst Ratings

Strong Buy

6 Buy

1 Hold

0 Sell

Based on 7 analysts giving stock ratings to

OrthoPediatrics

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

KIDS Stock 12 Month Forecast

Average Price Target

$36.43

▲(67.73%Upside)

Based on 7 Wall Street analysts offering 12 month price targets for OrthoPediatrics in the last 3 months. The average price target is $36.43 with a high forecast of $50.00 and a low forecast of $26.00. The average price target represents a 67.73% change from the last price of $21.72.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"$18","51":"$51","26.25":"$26.3","34.5":"$34.5","42.75":"$42.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$50.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$36.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$26.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,26.25,34.5,42.75,51],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.96,22.270769230769233,24.581538461538464,26.892307692307693,29.203076923076924,31.513846153846156,33.824615384615385,36.135384615384616,38.44615384615385,40.75692307692308,43.06769230769231,45.378461538461536,47.689230769230775,{"y":50,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.96,21.22692307692308,22.493846153846153,23.76076923076923,25.02769230769231,26.294615384615383,27.56153846153846,28.82846153846154,30.095384615384617,31.36230769230769,32.62923076923077,33.896153846153844,35.16307692307692,{"y":36.43,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.96,20.424615384615386,20.88923076923077,21.353846153846156,21.818461538461538,22.283076923076923,22.747692307692308,23.212307692307693,23.676923076923078,24.14153846153846,24.606153846153845,25.07076923076923,25.535384615384615,{"y":26,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":31.04,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.58,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.21,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.53,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.95,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.89,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.36,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.93,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.18,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.22,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.05,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.93,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$50.00

Average Price Target$36.43

Lowest Price Target$26.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$24

Hold

10.50%

Upside

Reiterated

06/12/25

OrthoPediatrics' score reflects solid revenue growth and positive sentiment from recent earnings, offset by ongoing profitability and cash flow challenges. Technical indicators suggest cautious optimism, while valuation concerns persist due to negative earnings.

Rick WiseStifel Nicolaus

Stifel Nicolaus

$32

Buy

47.33%

Upside

Reiterated

06/06/25

Stifel Nicolaus Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

Ryan ZimmermanBTIG

BTIG

$38

Buy

74.95%

Upside

Reiterated

05/18/25

Strong Market Position and Growth Potential Justify Buy Rating for OrthoPediatrics

Richard NewitterTruist Financial

Truist Financial

$24→$26

Hold

19.71%

Upside

Reiterated

05/09/25

Truist Financial Sticks to Its Hold Rating for OrthoPediatrics (KIDS)

Matthew O'BrienPiper Sandler

Piper Sandler

$40→$30

Buy

38.12%

Upside

Reiterated

05/08/25

Analysts Offer Insights on Healthcare Companies: QuidelOrtho (NASDAQ: QDEL), Outset Medical (NASDAQ: OM) and OrthoPediatrics (NASDAQ: KIDS)

Michael MatsonNeedham

Needham

$42

Buy

93.37%

Upside

Reiterated

05/08/25

OrthoPediatrics: Sustained Growth Potential and Positive Outlook Amid Revenue Guidance Increase

Ben HaynorLake Street

Lake Street

$37

Buy

70.35%

Upside

Reiterated

05/08/25

Lake Street Sticks to Their Buy Rating for OrthoPediatrics (KIDS)

David TurkalyCitizens JMP

Citizens JMP

$50

Buy

130.20%

Upside

Reiterated

03/21/25

OrthoPediatrics: Strong Market Position and Growth Potential Justify Buy Rating with $50 Price Target

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$24

Hold

10.50%

Upside

Reiterated

06/12/25

Rick WiseStifel Nicolaus

Stifel Nicolaus

$32

Buy

47.33%

Upside

Reiterated

06/06/25

Stifel Nicolaus Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

Ryan ZimmermanBTIG

BTIG

$38

Buy

74.95%

Upside

Reiterated

05/18/25

Strong Market Position and Growth Potential Justify Buy Rating for OrthoPediatrics

Richard NewitterTruist Financial

Truist Financial

$24→$26

Hold

19.71%

Upside

Reiterated

05/09/25

Truist Financial Sticks to Its Hold Rating for OrthoPediatrics (KIDS)

Matthew O'BrienPiper Sandler

Piper Sandler

$40→$30

Buy

38.12%

Upside

Reiterated

05/08/25

Analysts Offer Insights on Healthcare Companies: QuidelOrtho (NASDAQ: QDEL), Outset Medical (NASDAQ: OM) and OrthoPediatrics (NASDAQ: KIDS)

Michael MatsonNeedham

Needham

$42

Buy

93.37%

Upside

Reiterated

05/08/25

OrthoPediatrics: Sustained Growth Potential and Positive Outlook Amid Revenue Guidance Increase

Ben HaynorLake Street

Lake Street

$37

Buy

70.35%

Upside

Reiterated

05/08/25

Lake Street Sticks to Their Buy Rating for OrthoPediatrics (KIDS)

David TurkalyCitizens JMP

Citizens JMP

$50

Buy

130.20%

Upside

Reiterated

03/21/25

OrthoPediatrics: Strong Market Position and Growth Potential Justify Buy Rating with $50 Price Target

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering OrthoPediatrics

1 Month

xxx

Success Rate

16/28 ratings generated profit

Average Return

+1.38%

reiterated a xxx

rating 27 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +1.38% per trade.

3 Months

xxx

Success Rate

14/28 ratings generated profit

Average Return

+0.48%

reiterated a xxx

rating 27 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.48% per trade.

1 Year

Rick WiseStifel Nicolaus

Success Rate

8/23 ratings generated profit

Average Return

-7.97%

reiterated a buy rating 8 days ago

Copying Rick Wise's trades and holding each position for 1 Year would result in 34.78% of your transactions generating a profit, with an average return of -7.97% per trade.

2 Years

xxx

Success Rate

4/23 ratings generated profit

Average Return

-15.47%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 17.39% of your transactions generating a profit, with an average return of -15.47% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KIDS Analyst Recommendation Trends

Rating

Jan 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, KIDS has received 9 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. KIDS average Analyst price target in the past 3 months is 36.43.

Each month's total comprises the sum of three months' worth of ratings.

KIDS Financial Forecast

KIDS Earnings Forecast

Next quarter’s earnings estimate for KIDS is -$0.29 with a range of -$0.38 to -$0.17. The previous quarter’s EPS was -$0.39. KIDS beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.45% of the time in the same period. In the last calendar year KIDS has Outperformed its overall industry.

KIDS Sales Forecast

Next quarter’s sales forecast for KIDS is $61.39M with a range of $61.00M to $62.37M. The previous quarter’s sales results were $52.41M. KIDS beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 57.14% of the time in the same period. In the last calendar year KIDS has Outperformed its overall industry.

KIDS Stock Forecast FAQ

What is KIDS’s average 12-month price target, according to analysts?

Based on analyst ratings, OrthoPediatrics Corp’s 12-month average price target is 36.43.

What is KIDS’s upside potential, based on the analysts’ average price target?

OrthoPediatrics Corp has 67.73% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is KIDS a Buy, Sell or Hold?

OrthoPediatrics Corp has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.

What is OrthoPediatrics Corp’s price target?

The average price target for OrthoPediatrics Corp is 36.43. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $50.00 ,the lowest forecast is $26.00. The average price target represents 67.73% Increase from the current price of $21.72.

What do analysts say about OrthoPediatrics Corp?

OrthoPediatrics Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of KIDS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

OrthoPediatrics (KIDS) Stock Forecast & Price Target

KIDS Analyst Ratings

KIDS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering OrthoPediatrics

KIDS Analyst Recommendation Trends

KIDS Financial Forecast

KIDS Earnings Forecast

KIDS Sales Forecast

KIDS Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts